As of June 20, 2025, Phoenix Life Sciences International Ltd (PLSI) reports a Gross Margin of 27.05%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Phoenix Life Sciences International Ltd's Gross Margin
Over recent years, Phoenix Life Sciences International Ltd's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2019-02-28 | 27.05% |
| 2018-02-28 | 27.05% |
| 2017-02-28 | -104.46% |
| 2016-02-29 | - |
This slight downward trend highlights how Phoenix Life Sciences International Ltd manages its operational efficiency and pricing power over time.
Comparing Phoenix Life Sciences International Ltd's Gross Margin to Peers
To better understand Phoenix Life Sciences International Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Phoenix Life Sciences International Ltd (PLSI) | 27.05% |
| Sunset Island Group Inc (SIGO) | 7775.20% |
| RespireRx Pharmaceuticals Inc (RSPI) | 7775.20% |
| NanoSphere Health Sciences Inc (NSHS.CN) | 7775.20% |
| Nouveau Life Pharmaceuticals Inc (NOUV) | 7775.20% |
| Provention Bio Inc (PRVB) | 96.03% |
Compared to its competitors, Phoenix Life Sciences International Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.